Informa Life Sciences will be holding its 23rd Annual EU Pharmaceutical Law Forum on May 14-15, 2014 in Brussels, Belgium.  The conference will offer presentations on the following topics:

• Feedback from the EU Commission on competition law (keynote presentation) — to be presented by a representative from DG Competition, European Commission;
• Reverse payment patent settlements;
• Examining parallel trade: Imports and exports;
• Relationship between pharmaceutical companies and wholesales/distributors: Assessing the competition law aspects;
• Review of high profile national cases/decisions in competition law;
• Unified Patent Court: Feedback from the European Commission (keynote presentation) — to be presented by François Arbault, Head of Unit, European Commission;
• Interface between competition law, IP and the regulatory frameworks;
• Understanding European patent and SPC litigation: Changes ahead (evening seminar discussion and dinner);
• Implementation of the EU regulatory framework for medicinal products for human use (keynote presentation) — to be presented by Olga Solomon, Deputy Head of Unit D5 – Medicinal Products – Authorisations, European Medicines Agency, DG Health and Consumers, European Commission;
• Transparency of pre-clinical and clinical trial data and other regulatory data;
• Review of the clinical trials regulation;
• Evaluating data exclusivity/Regulatory Data Protection (RDP) in the pharmaceutical industry;
• Interaction with healthcare professionals – challenges and changes;
• New trends in pricing and reimbursement and revisions to the EU Transparency Directive: Main focus on France, Germany, Spain, Italy and the UK;
• Practical experience of the new pharmacovigilance legislation;
• Feedback from the EU Commission on the EU regulatory framework for medical devices (keynote presentation) — to be presented by Despina Spanou, Director for Consumer Affairs, European Commission;
• Examining the use of medical devices;
• Overcoming challenges surrounding personalised medicines and IVDs;
• Reviewing combination and borderline products;
• Biosimilars and the regulatory frameworks; and
• Examining pharmaceutical advertising, social media and health apps (evening seminar discussion and dinner).

A complete brochure for this conference, including an agenda, detailed descriptions of conference sessions, list of speakers, and registration form can be obtained here.

The registration fee for the conference is £1632.29 (1 Day Pass — conference and evening seminar for day 1 or 2), £2055.79 (2 Day Pass — conference only), £2660.79 (2 Day Pass — conference and one evening seminar), or £3023.79 (Full Pass — conference and evening seminar for days 1 and 2.  Those registering by April 11, 2014 will receive a £100 discount.  Those interested in registering for the conference can do so here, by e-mailing registrations@informa-ls.com, by calling +44(0) 20 7017 7481, or by faxing a registration form to +44(0) 20 7017 7823.

Patent Docs is a media partner of the EU Pharmaceutical Law Forum.